Retatrutide Surpasses Incretin Threshold in T2D at EASD 2026 | Retatrutide News

Retatrutide has shown potential to surpass the 'incretin ceiling' in managing Type 2 Diabetes, according to TRIUMPH-2 data presented at EASD 2026. This ...
Clinical Trials · October 19, 2026